Topics

lipid nanoparticles

"Spherical vesicles made of ionizable lipids, which are positively charged at low pH (enabling RNA complexation) and neutral at physiological pH (reducing potential toxic effects, as compared with positively charged lipids, such as liposomes)."  
 
 
"When the mRNA COVID-19 vaccine is injected into the arm, these LNP delivery vehicles shuttle the mRNA instructions into cells. The instructions are then unloaded, and the cell can make the spike protein ..."  Source:  https://www.pfizer.com/news/behind-the-science/inside-delivery-vehicles-critical-success 
‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
A Case Report of Acute Lymphoblastic Leukaemia (ALL)/Lymphoblastic Lymphoma (LBL) Following the Second Dose of Comirnaty®: An Analysis of the Potential Pathogenic Mechanism Based on of the Existing Literature
A GMO Experiment on Two-Thirds of the World’s Population: Reaction to Ulrich’s Commentary on Lee and Broudy
Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE)
Adjuvant Activity and Toxicological Risks of Lipid Nanoparticles Contained in the COVID-19 “mRNA Vaccines"
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis
Adverse effects of COVID-19 vaccines and measures to prevent them
Alternate mechanisms of mRNA vaccine toxicity: which one is the main culprit?
Anaphylaxis to Pfizer/BioNTech mRNA COVID-19 Vaccine in a Patient With Clinically Confirmed PEG Allergy
Anaphylaxis-Induced Acute Coronary Syndrome Following Covid-19 mRNA-LNP Vaccination: Mechanisms and Therapeutic Approaches
Assessment report: COVID-19 Vaccine Moderna
Barrier Capacity of Human Placenta for Nanosized Materials
BioNTech RNA-Based COVID-19 Injections Contain Large Amounts Of Residual DNA Including An SV40 Promoter/Enhancer Sequence
Chemical-physical criticality and toxicological potential of lipid nanomaterials contained in a COVID-19 mRNA vaccine
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
COVID-19 vaccines – An Australian Review
Cytokine Storms and Anaphylaxis Following COVID-19 mRNA-LNP Vaccination: Mechanisms and Therapeutic Approaches
Do Messenger RNA Vaccines Induce Pathological Syncytia?
Maternal COVID-19 Vaccination and Its Potential Impact on Fetal and Neonatal Development
Methodological Considerations Regarding the Quantification of DNA Impurities in the COVID-19 mRNA Vaccine Comirnaty®
mRNA "vaccine" biodistribution, persistence, and adjuvant toxicity library
mRNA Vaccine Toxicity
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning
Nanotechnology: Self Assembly Structures in mRNA-Injections
No Nanobots in Vaccines — Just Lipids on the Loose
Pfizer/BioNTech’s COVID-19 modRNA Vaccines: Dangerous Genetic Mechanism of Action Released before Sufficient Preclinical Testing
Potential Conscientious Objection to mRNA Technology as Preventive Treatment for COVID-19
Response to Critics of Lee & Broudy (2024) on the Toxicity and Self-Assembling Technology in Incubated Samples of Injecta
Safe Nanoparticles: Are We There Yet?
SARS-CoV-2 and the Vaccination Hype
Spike Protein Leads to ‘Five Mechanisms of Damage’ in Human Body
Strategies for the Management of Spike Protein-Related Pathology
Testimony of Robert Redfield in senate hearing on 'Risky Research: Oversight of U.S. Taxpayer Funded High-Risk Virus Research'
The conundrum of COVID-19 mRNA vaccine–induced anaphylaxis
The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines
The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review
1484